Perinatal depression, defined as major depressive episodes that occur either during pregnancy or within the first 6 months postpartum, can have devastating consequences for the woman, her children and her family. In particular, postpartum depression (PPD) has a prevalence rate of approximately 10%, making it one of the most common complications of both the prenatal and postpartum period. The pathogenesis of PPD is likely a complicated interplay of alterations in HPA stress axis reactivity mediated by genetic contributions. Our goal is to integrate two promising models of psychiatric illness: psychoneuroendocrinology and genetics. The basis for our conceptual model has two main hypotheses: 1) change in levels rather than direction of change of gonadal hormones may trigger mood disorders;2) genetic variants in stress axis reactivity may predispose to depression in times of flux of gonadal hormones. My long-term career goal is to understand the pathogenesis of PPD, so that an optimal screening strategy that prospectively identifies those at risk of PPD can be developed. PPD may be a more homogeneous subset of major depressive disorder (MDD) suggested by its linkage to a puerperal endocrine trigger that is more amenable to searches for biomarkers.
In Aim 1, we will compare HPA axis stress reactivity using both physiological (dexamethasone/CRH) and psychological (Trier Social Stress Test) challenges in euthymic women with a history of PPD, women with a history of non-puerperal MDD, and control women without a history of MDD.
In Aim 2, we will conduct secondary analyses of an existing genomewide association dataset for PPD. All 3,540 subjects are from the Netherlands and were genotyped by Perlegen Sciences for 435,291 SNPs that tag common genetic variation in Europeans as part of the Foundation for the NIH GAIN study of MDD. Specifically, we will: a) conduct PPD phenotyping in GAIN MDD cases;b) perform an hypothesis-driven association of PPD for SNPs (36 candidate genes;572 SNPs) in three groups, (women with a history of MDD (non-puerperal), women with a history of MDD and PPD, and normal controls);and c) using all other SNPs not part of Aim 2b (434,719 SNPs), perform a hypothesis-generating genomewide association study (GWAS) of PPD.

Public Health Relevance

The public health relevance of this research is that its successful completion could allow for identification of specific markers for screening of PPD in women during the perinatal period. The disease burden of PPD is high and is a large source of health care costs. We propose to conduct cutting edge biomedical research that may allow us to identify and intervene in more productive, prospective ways for women at risk for PPD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23MH085165-05
Application #
8424307
Study Section
Adult Psychopathology and Disorders of Aging Study Section (APDA)
Program Officer
Wynne, Debra K
Project Start
2009-07-01
Project End
2014-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
5
Fiscal Year
2013
Total Cost
$172,830
Indirect Cost
$12,802
Name
University of North Carolina Chapel Hill
Department
Psychiatry
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ferguson, Elizabeth H; Di Florio, Arianna; Pearson, Brenda et al. (2017) HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression. Arch Womens Ment Health 20:411-420
Di Florio, A; Putnam, K; Altemus, M et al. (2017) The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychol Med 47:787-799
Lara-Cinisomo, Sandraluz; Grewen, Karen M; Girdler, Susan S et al. (2017) Perinatal Depression, Adverse Life Events, and Hypothalamic-Adrenal-Pituitary Axis Response to Cold Pressor Stress in Latinas: An Exploratory Study. Womens Health Issues 27:673-682
Jha, Shaili C; Meltzer-Brody, Samantha; Steiner, Rachel J et al. (2016) Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Psychiatry Res Neuroimaging 253:43-53
Viktorin, Alexander; Meltzer-Brody, Samantha; Kuja-Halkola, Ralf et al. (2016) Heritability of Perinatal Depression and Genetic Overlap With Nonperinatal Depression. Am J Psychiatry 173:158-65
Stuebe, Alison M; Meltzer-Brody, Samantha; Pearson, Brenda et al. (2015) Maternal neuroendocrine serum levels in exclusively breastfeeding mothers. Breastfeed Med 10:197-202
Schiller, Crystal Edler; Meltzer-Brody, Samantha; Rubinow, David R (2015) The role of reproductive hormones in postpartum depression. CNS Spectr 20:48-59
Alvarez, Shanna L; Meltzer-Brody, Samantha; Mandel, Marcia et al. (2015) Maternal Depression and Early Intervention: A Call for an Integration of Services. Infants Young Child 28:72-87
Cox, E Q; Stuebe, A; Pearson, B et al. (2015) Oxytocin and HPA stress axis reactivity in postpartum women. Psychoneuroendocrinology 55:164-72
Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium (2015) Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry 2:59-67

Showing the most recent 10 out of 24 publications